Azienda Ospedaliera S.Giuseppe Moscati - Academic Profile

Publications

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

Luis Paz‐Ares , Filippo de Marinis , Mircea Dediu +14 more

2012 The Lancet Oncology 605 citations

Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies

Jessica Davies , Manali I. Patel , Cesare Gridelli +3 more

Most patients with advanced non-small cell lung cancer (NSCLC) have a poor prognosis and receive limited benefit from conventional treatments, especially in later lines of thera...

2017 PLoS ONE 83 citations

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials

Giorgio V. Scagliotti , Cesare Gridelli , Filippo de Marinis +10 more

2014 Lung Cancer 23 citations

Affiliated Researchers

Cesare Gridelli

Azienda Ospedaliera S.Giuseppe Moscati

Institution Info

Type: healthcare
Country: IT
Publications: 3
Citations: 711

External Links

Identifiers

ROR: https://ror.org/021jxzw96